This unit provides a detailed overview of the processes involved in the development, production and regulation of complementary medicines and medicinal cannabis products devices (with a focus on herbal and nutritional supplement products). In this unit, students will learn about fundamental processes related to complementary medicine and medicinal cannabis production including the regulatory framework, relevant policies and ethical implications (including evidence claims) governing this industry, good cultivation practice (GCP) and manufacturing practice (GMP) and quality standards, submission of product dossiers requirements as well as internationalisation of complementary medicine and medicinal cannabis products (e.g. regulation in Asia and other key areas for export). Students will gain an understanding of the processes and guidelines involved in registering complementary medicine and medicinal cannabis products with the Therapeutic Goods Administration (TGA) in Australia and will be able to assess the level and quality of evidence to support the manufacturer's claim. This unit is suitable for postgraduate students who are working in or interested in entering the complementary medicine or medicinal cannabis development, manufacturing, and regulation sector.
Unit details and rules
Unit code | PHAR7815 |
---|---|
Academic unit | Pharmacy |
Credit points | 6 |
Prohibitions
?
|
None |
Prerequisites
?
|
None |
Corequisites
?
|
None |
Assumed knowledge
?
|
Students will be expected to have a relevant health care, health science or science related undergraduate qualification or experience working in this sector |
Available to study abroad and exchange students | No |
Teaching staff
Coordinator | Joanna Elizabeth Harnett, joanna.harnett@sydney.edu.au |
---|---|
Tutor(s) | Orin Chisholm, orin.chisholm@sydney.edu.au |